SCHEMBL11196413

SCHEMBL11196413

CC1CC(=O)NN=C1c1ccc(NC(=O)CF)cc1

nearest known ligand 0.73

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ PDE3B Q13370 17/20 0.73
▸ PDE3A Q14432 17/20 0.73
▸ KDM4E B2RXH2 1/20 0.59
▸ ALDH1A1 P00352 1/20 0.59
▸ CYP1A2 P05177 1/20 0.59
▸ CYP3A4 P08684 1/20 0.59
▸ ALOX15 P16050 1/20 0.59
▸ TSHR P16473 1/20 0.59
▸ MAPK1 P28482 1/20 0.59
▸ LMNA P02545 1/20 0.59
▸ BLM P54132 1/20 0.59
▸ NPSR1 Q6W5P4 1/20 0.59
▸ MAPT P10636 1/20 0.59
▸ SMN1; SMN2 Q16637 1/20 0.59
▸ TNNC1 P63316 1/20 0.57
▸ PDE4A P27815 4/20 0.51
▸ PDE4B Q07343 4/20 0.51
▸ PDE4C Q08493 4/20 0.51
▸ PDE4D Q08499 4/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11189228 0.92 PDE3B (0.72) PDE3BPDE3AKDM4EALDH1A1CYP1A2
SCHEMBL7312486 0.92 PDE3B (0.72) PDE3BPDE3AKDM4EALDH1A1CYP1A2
SCHEMBL10993762 0.89 PDE3B (0.75) PDE3BPDE3AKDM4EALDH1A1CYP1A2
SCHEMBL11185074 0.89 PDE3B (0.75) PDE3BPDE3AKDM4EALDH1A1CYP1A2
SCHEMBL11180354 0.88 PDE3B (0.77) PDE3BPDE3AKDM4EALDH1A1CYP1A2
SCHEMBL11338882 0.88 PDE3B (0.73) PDE3BPDE3AKDM4EALDH1A1CYP1A2
SCHEMBL10808986 0.88 PDE3B (0.73) PDE3BPDE3AKDM4EALDH1A1CYP1A2
SCHEMBL11500958 0.87 PDE3B (0.69) PDE3BPDE3AKDM4EALDH1A1CYP1A2
SCHEMBL10474968 0.87 PDE3B (0.72) PDE3BPDE3AKDM4EALDH1A1CYP1A2
SCHEMBL10474439 0.87 PDE3B (0.72) PDE3BPDE3AKDM4EALDH1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4376771-A ANTI-HYPERTENSIVE AGENTS AND ANTI-THROMBOTIC AGENTS BASF AKTIENGESELLSCHAFT (DE) 1983-03-15 — — US disclosed
EP-0000113-B1 DIHYDROPYRIDAZONES, THEIR PREPARATION AND MEDICINES CONTAINING THEM AND DIHYDROPYRIDAZONES FOR USE IN MEDICAL TREATMENTS BASF Aktiengesellschaft (DE) 1981-09-16 — — EP disclosed
EP-0000113-A1 Dihydropyridazones, their preparation and medicines containing them and dihydropyridazones for use in medical treatments BASF Aktiengesellschaft (DE) 1979-01-10 — — EP disclosed
Send feedback